Literature DB >> 24621472

Liver-specific angiotensinogen suppression: an old yet novel target for blood pressure control through RAS inhibition?

Kento Kitada1, Hiroyuki Kobori1, Akira Nishiyama1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24621472      PMCID： PMC4048945          DOI： 10.1038/hr.2014.54

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  12 in total

Review 1.  The incidence and implications of aldosterone breakthrough.

Authors:  Andrew S Bomback; Philip J Klemmer
Journal:  Nat Clin Pract Nephrol       Date:  2007-09

2.  Angiotensinogen: an attractive and underrated participant in hypertension and inflammation.

Authors:  J Ménard; A I el Amrani; F Savoie; J Bouhnik
Journal:  Hypertension       Date:  1991-11       Impact factor: 10.190

Review 3.  Pharmacologic interruption of the renin-angiotensin system and the kidney: differential responses to angiotensin-converting enzyme and renin inhibition.

Authors:  N K Hollenberg
Journal:  J Am Soc Nephrol       Date:  1999-01       Impact factor: 10.121

4.  Targeting of hepatic angiotensinogen using chemically modified siRNAs results in significant and sustained blood pressure lowering in a rat model of hypertension.

Authors:  Jeffrey Olearczyk; Sheng Gao; Marianne Eybye; Satyasri Yendluri; Lori Andrews; Steven Bartz; Doris Cully; Marija Tadin-Strapps
Journal:  Hypertens Res       Date:  2013-12-12       Impact factor: 3.872

5.  Genetic control of blood pressure and the angiotensinogen locus.

Authors:  H S Kim; J H Krege; K D Kluckman; J R Hagaman; J B Hodgin; C F Best; J C Jennette; T M Coffman; N Maeda; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

6.  Role of angiotensinogen in blood pressure homeostasis.

Authors:  J Gardes; J Bouhnik; E Clauser; P Corvol; J Menard
Journal:  Hypertension       Date:  1982 Mar-Apr       Impact factor: 10.190

7.  Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats.

Authors:  Mitsuhide Naruse; Akiyo Tanabe; Atsuhisa Sato; Sachiko Takagi; Ken Tsuchiya; Toshihiro Imaki; Kazue Takano
Journal:  Hypertension       Date:  2002-07       Impact factor: 10.190

8.  Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects.

Authors:  W G Walker; P K Whelton; H Saito; R P Russell; J Hermann
Journal:  Hypertension       Date:  1979 May-Jun       Impact factor: 10.190

9.  Angiotensinogen-deficient mice with hypotension.

Authors:  K Tanimoto; F Sugiyama; Y Goto; J Ishida; E Takimoto; K Yagami; A Fukamizu; K Murakami
Journal:  J Biol Chem       Date:  1994-12-16       Impact factor: 5.157

10.  High blood pressure in transgenic mice carrying the rat angiotensinogen gene.

Authors:  S Kimura; J J Mullins; B Bunnemann; R Metzger; U Hilgenfeldt; F Zimmermann; H Jacob; K Fuxe; D Ganten; M Kaling
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598
View more
  2 in total

1.  High Intensity Interval Training Favourably Affects Angiotensinogen mRNA Expression and Markers of Cardiorenal Health in a Rat Model of Early-Stage Chronic Kidney Disease.

Authors:  Patrick S Tucker; Aaron T Scanlan; Vincent J Dalbo
Journal:  Biomed Res Int       Date:  2015-05-24       Impact factor: 3.411

2.  The transcriptional regulation of the human angiotensinogen gene after high-fat diet is haplotype-dependent: Novel insights into the gene-regulatory networks and implications for human hypertension.

Authors:  Anita Rana; Sudhir Jain; Nitin Puri; Meenakshi Kaw; Natalie Sirianni; Deniz Eren; Brahma Raju Mopidevi; Ashok Kumar
Journal:  PLoS One       Date:  2017-05-03       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.